We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-2.07%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$19.3B
AUM Growth
-$803M
Cap. Flow
+$159M
Cap. Flow %
0.82%
Top 10 Hldgs %
30.79%
Holding
732
New
52
Increased
325
Reduced
233
Closed
41

Top Buys

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$78.3M
2
NEE icon
NextEra Energy
NEE
+$57M
3
NVDA icon
NVIDIA
NVDA
+$48M
4
BABA icon
Alibaba
BABA
+$43.4M
5
AAPL icon
Apple
AAPL
+$39M

Top Sells

Rank Stock Value
1
NU icon
Nu Holdings
NU
+$87.5M
2
RVMD icon
Revolution Medicines
RVMD
+$45.5M
3
ABT icon
Abbott
ABT
+$44.5M
4
JPM icon
JPMorgan Chase
JPM
+$44.3M
5
IQV icon
IQVIA
IQV
+$43M

Sector Composition

Rank Sector Weight
1 Technology 32.73%
2 Healthcare 27.11%
3 Financials 9.44%
4 Consumer Discretionary 7.72%
5 Communication Services 7.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMI icon
326
Cummins
CMI
$91.1B
$7.47M 0.04%
13,883
+413
+3% +$234K
SMTC icon
327
Semtech
SMTC
$12.8B
$7.47M 0.04%
+97,140
New +$7.99M
VRSK icon
328
Verisk Analytics
VRSK
$25.6B
$7.42M 0.04%
39,110
+4,774
+14% +$969K
WDAY icon
329
Workday
WDAY
$34.9B
$7.38M 0.04%
56,782
-4,140
-7% -$657K
GM icon
330
General Motors
GM
$71.7B
$7.34M 0.04%
98,578
-4,101
-4% -$326K
EBAY icon
331
eBay
EBAY
$50.2B
$7.32M 0.04%
80,476
-417,847
-84% -$37.5M
ALLO icon
332
Allogene Therapeutics
ALLO
$639M
$7.31M 0.04%
2,997,318
+691,674
+30% +$1.39M
ORIC icon
333
Oric Pharmaceuticals
ORIC
$1.12B
$7.27M 0.04%
+574,085
New +$6.52M
GWW icon
334
W.W. Grainger
GWW
$64.3B
$7.25M 0.04%
6,643
+515
+8% +$563K
ZWS icon
335
Zurn Elkay Water Solutions
ZWS
$7.89B
$7.18M 0.04%
160,164
+5,199
+3% +$248K
SSD icon
336
Simpson Manufacturing
SSD
$7.63B
$7.13M 0.04%
+41,560
New +$7.66M
HAS icon
337
Hasbro
HAS
$12.6B
$7.08M 0.04%
75,609
+11,159
+17% +$1.04M
MHK icon
338
Mohawk Industries
MHK
$6.6B
$7.05M 0.04%
71,589
-56,811
-44% -$6.62M
VC icon
339
Visteon
VC
$2.78B
$7.04M 0.04%
77,242
-1,628
-2% -$154K
MNST icon
340
Monster Beverage
MNST
$92.4B
$7.01M 0.04%
96,770
+39,048
+68% +$3.08M
EXPD icon
341
Expeditors International
EXPD
$23.4B
$6.88M 0.04%
48,066
+25,955
+117% +$3.94M
PCAR icon
342
PACCAR
PCAR
$66.4B
$6.78M 0.04%
58,695
+20,478
+54% +$2.48M
KR icon
343
Kroger
KR
$35.4B
$6.78M 0.04%
93,634
+17,075
+22% +$1.16M
SHW icon
344
Sherwin-Williams
SHW
$78.5B
$6.73M 0.04%
20,992
+1,198
+6% +$412K
EHC icon
345
Encompass Health
EHC
$11.1B
$6.71M 0.03%
+69,375
New +$7.11M
GAP
346
The Gap Inc
GAP
$7.06B
$6.62M 0.03%
273,363
+260,078
+1,958% +$6.88M
STT icon
347
State Street
STT
$50.4B
$6.61M 0.03%
52,201
-8,006
-13% -$1.02M
ULS icon
348
UL Solutions
ULS
$17.2B
$6.45M 0.03%
75,298
-1,588
-2% -$125K
OKE icon
349
Oneok
OKE
$57.9B
$6.41M 0.03%
70,947
+8,654
+14% +$713K
BMI icon
350
Badger Meter
BMI
$4.26B
$6.4M 0.03%
42,025
-5,272
-11% -$828K

Similar funds

Candriam SCA's Q1 2026 Portfolio in Review

As of Q1 2026, Candriam SCA held 732 positions worth $19.3B, down 4% from $20.1B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Candriam SCA's Q1 2026 filing shows 52 new, 325 increased, 233 reduced and 41 closed positions. Its largest new stake was Service Corp International: 360,195 shares worth $29.7M. The largest sale was Nu Holdings, an estimated $87.5M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q1 2026 buy was Service Corp International: 360,195 shares worth $29.7M.
  • Candriam SCA added most to KLA in Q1 2026, an estimated $78.3M increase.
  • Candriam SCA's biggest Q1 2026 reduction was Nu Holdings, cutting an estimated $87.5M.
  • Candriam SCA fully exited Banco Macro in Q1 2026, selling an estimated $25.6M.
  • Candriam SCA's ten largest holdings make up 31% of its $19.3B portfolio in Q1 2026.
  • Candriam SCA opened 52 new positions and closed 41 in Q1 2026.
  • Candriam SCA's portfolio value fell 4% quarter-over-quarter to $19.3B.

Based on Candriam SCA's 13F filing for Q1 2026, filed 30 Apr 2026.